DK1917029T3 - Fremgangsmåde til at behandle cancerceller og skabe en modificeret cancercelle, som provokerer et immunogent respons - Google Patents

Fremgangsmåde til at behandle cancerceller og skabe en modificeret cancercelle, som provokerer et immunogent respons

Info

Publication number
DK1917029T3
DK1917029T3 DK06774696.6T DK06774696T DK1917029T3 DK 1917029 T3 DK1917029 T3 DK 1917029T3 DK 06774696 T DK06774696 T DK 06774696T DK 1917029 T3 DK1917029 T3 DK 1917029T3
Authority
DK
Denmark
Prior art keywords
provokes
creating
immunogenic response
cancer cells
cancer cell
Prior art date
Application number
DK06774696.6T
Other languages
English (en)
Inventor
Moiz Kitabwalla
Hassibullah Akeefe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1917029T3 publication Critical patent/DK1917029T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464454—Enzymes
    • A61K39/464456—Tyrosinase or tyrosinase related proteinases [TRP-1 or TRP-2]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • A61K39/464492—Glycoprotein 100 [Gp100]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK06774696.6T 2005-07-27 2006-07-26 Fremgangsmåde til at behandle cancerceller og skabe en modificeret cancercelle, som provokerer et immunogent respons DK1917029T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70269105P 2005-07-27 2005-07-27
PCT/US2006/028933 WO2007016130A2 (en) 2005-07-27 2006-07-26 A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response

Publications (1)

Publication Number Publication Date
DK1917029T3 true DK1917029T3 (da) 2013-04-29

Family

ID=37709132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06774696.6T DK1917029T3 (da) 2005-07-27 2006-07-26 Fremgangsmåde til at behandle cancerceller og skabe en modificeret cancercelle, som provokerer et immunogent respons

Country Status (8)

Country Link
US (3) US7361360B2 (da)
EP (2) EP2623116A1 (da)
JP (4) JP2009502933A (da)
CA (1) CA2616344C (da)
DK (1) DK1917029T3 (da)
ES (1) ES2401706T3 (da)
PT (1) PT1917029E (da)
WO (1) WO2007016130A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US7641643B2 (en) * 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US7361360B2 (en) * 2005-07-27 2008-04-22 Lipid Sciences, Inc. Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
US7732190B2 (en) * 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) * 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9005672B2 (en) * 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
PL2591798T3 (pl) 2011-11-09 2015-04-30 Werner Lubitz Szczepionka do zastosowania w immunoterapii nowotworów
EP3195878A1 (en) 2016-01-22 2017-07-26 Werner Lubitz Bacterial ghosts for the treatment of cancer
WO2017136633A1 (en) * 2016-02-04 2017-08-10 Duke University Cell-based vaccine compositions and methods of use
CN109153728A (zh) * 2016-03-21 2019-01-04 埃尔斯塔治疗公司 多特异性和多功能分子及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665297B2 (ja) * 1985-11-01 1994-08-24 小野 啓郎 新規細胞株
KR100363587B1 (ko) * 1999-11-12 2002-12-06 이시우 대식세포와 종양세포의 융합에 의한 항종양 세포성 치료제
EP1130088A1 (en) * 2000-02-27 2001-09-05 Eberhard-Karls-Universität Tübingen Universitätsklinikum Hybrid cell vaccines
US7439052B2 (en) 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407663B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
AUPQ846900A0 (en) 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407662B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
CU23002A1 (es) 2000-12-01 2004-11-18 Ct Ingenieria Genetica Biotech Método de obtención de agregados antigénicos y su uso en formulaciones
EP1412045A4 (en) 2001-06-25 2007-05-02 Lipid Sciences Inc A SOLVENT FOR REMOVING LIPIDES FROM FLUIDS USING SYSTEMS AND METHOD
US20060060520A1 (en) 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US20030127386A1 (en) 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
AU2002322284A1 (en) 2001-06-25 2003-01-08 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US6991727B2 (en) 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
AU2003268190B2 (en) 2002-08-26 2008-04-03 Eli Lilly And Company Treating Alzheimers using delipidated protein particles
JP2007524383A (ja) * 2003-06-20 2007-08-30 リピッド サイエンシーズ，インコーポレイテッド 感染性疾患を処置及び予防するのに有用な免疫原性特性を有し脂質含量の低減した改変されたウイルス粒子
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US7361360B2 (en) * 2005-07-27 2008-04-22 Lipid Sciences, Inc. Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response

Also Published As

Publication number Publication date
US20080187559A1 (en) 2008-08-07
US7740872B2 (en) 2010-06-22
US7361360B2 (en) 2008-04-22
ES2401706T3 (es) 2013-04-23
WO2007016130A3 (en) 2009-04-30
EP1917029B1 (en) 2013-01-23
US20100215698A1 (en) 2010-08-26
US8435531B2 (en) 2013-05-07
PT1917029E (pt) 2013-03-13
CA2616344C (en) 2010-10-12
EP1917029A4 (en) 2010-07-07
WO2007016130A2 (en) 2007-02-08
EP1917029A2 (en) 2008-05-07
JP2009001577A (ja) 2009-01-08
EP2623116A1 (en) 2013-08-07
JP2009242420A (ja) 2009-10-22
JP2013116925A (ja) 2013-06-13
JP2009502933A (ja) 2009-01-29
US20070026006A1 (en) 2007-02-01
CA2616344A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
DK1917029T3 (da) Fremgangsmåde til at behandle cancerceller og skabe en modificeret cancercelle, som provokerer et immunogent respons
EG25108A (en) Washing apparatus and washing method for solar panels.
TWI371688B (en) An apparatus, method and system perform transactional memory operations
DK2044120T3 (da) Antistoffer, der genkender en kulhydratholdig epitop på cd-43 og cea eksprimeret på cancerceller, og fremgangsmåder til anvendelse deraf
PL2266544T3 (pl) Sposób wprowadzania substancji terapeutycznych do komórek
EP1854219A4 (en) METHOD, APPARATUS AND SYSTEM FOR TRANSMITTING ENERGY
GB0517113D0 (en) Methods, apparatus and computer programs for data communication efficiency
EP1843344A4 (en) REPRODUCTION DEVICE, PROGRAM THEREOF, AND REPRODUCTION METHOD
GB0501553D0 (en) Method and apparatus for energy generation
EP1866868A4 (en) Album generating apparatus, album generating method and program
EP1866869A4 (en) Album generating apparatus, album generating method and program
GB0622187D0 (en) Layout design support system, method, and program
NO20052613D0 (no) Fremgangsmate, system og anordning for a tilby arbeidsbokomrader som datakilder
IL191556A0 (en) Solar system and method for the operation thereof
EP1956608A4 (en) ELECTRON BEAM APPLICATION METHOD, ELECTRON BEAM APPLICATION DEVICE, ELECTRON BEAM APPLICATION DEVICE FOR CONTAINER EQUIPPED WITH AN OPENING
EP1710799A4 (en) REPRODUCTION DEVICE, PROGRAM, AND METHOD
IL185798A0 (en) Pharmacological, chemical and topical agent enhancement apparatus and method for using same
EP2179556A4 (en) METHOD FOR GENERATING FRAME FOR DOWNLINK, AND METHOD FOR SEARCHING CELL
EP1921188A4 (en) MACHINE SIMULATION SYSTEM, ITS METHOD AND ITS PROGRAM
NO20051559L (no) System og fremgangsmate for utnyttelse av energi
EP1816101A4 (en) STEAM REFORMING DEVICE AND METHOD FOR STEAM REFORMING THEREFOR AND TECHNICAL OVEN
EP2097994A4 (en) METHOD FOR GENERATING A DOWNLINK SIGNAL AND METHOD FOR CELL SEARCHING
ZA200609711B (en) Process for uranium recovery
GB0522124D0 (en) User-interface system, method & apparatus
BRPI0717469A2 (pt) Cultura de células vero, e, método para propagar um vírus em células vero.